CVS Health Analyst Ratings
Wells Fargo Adjusts Price Target on CVS Health to $61 From $60, Maintains Equalweight Rating
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Truist Financial Sticks to Their Buy Rating for CVS Health (CVS)
Hold Rating on CVS Health Amidst Anticipated Earnings Pressure and Segment Challenges
The U.S. Uninsured Rate Hits 8%, a Post-pandemic High
12 Out of 17 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
CVS Health Is Maintained at Hold by Deutsche Bank
CVS Health Price Target Cut to $63.00/Share From $64.00 by Deutsche Bank
What's Going On With CVS Health Stock?
Top Midday Stories: E.l.f. Beauty Falls After Earnings; JetBlue's Potential Bond Sale; Perrigo Recalls Baby Formula; Cisco's Job Cuts
Decoding CVS Health's Options Activity: What's the Big Picture?
74 S&P 500 Stocks That Can Beat the Cash Yield - BofA
E.l.f. Not Doing Enough Progress With Retailers Beyond Target -- Market Talk
HSBC Adjusts Price Target on CVS Health to $61 From $62
Analysts' Opinions Are Mixed on These Healthcare Stocks: CVS Health (CVS), Insulet (PODD) and Artivion (AORT)
CVS Health (CVS) Receives a Rating Update From a Top Analyst
Perrigo Recalls 16,500 Cans of Baby Formula Due to Elevated Vitamin D Levels
CVS Health Corporation (NYSE:CVS) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula